1 / 1

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2015

“Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2015” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry.<br>For more information: http://bit.ly/25aBOz4

richa21
Download Presentation

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2015 Channel sales partner Deal Values in Pharmaceutical & Healthcare Industry Increased in Q4 2015 Number of Deals Q4 2014–Q4 2015 1,500 1,283 1,198 1,143 Jun-15 1,053 Dec-14 Mar-15 483 1,013 Sep-15 1,000 No. of Deals Dec-15 462 412 314 344 May-15 Aug-15 Feb-15 Nov-14 Nov-15 396 331 312 326 500 327 Jan-15 Oct-14 Jul-15 Apr-15 Oct-15 Q4 2015 424 408 405 404 342 0 Q4 2014 Q1 2015 Q2 2015 Q3 2015 Deal Volume Last Five Quarters Source: GlobalData - Pharma eTrack Deals Database The pharmaceutical and healthcare industry reported an increase in deal value in Q4 2015 with USD237.7 billion compared to USD201.3 billion in Q4 2014. However, the number of deals decreased in Q4 2015 with 1,013, as compared to 1,143 in Q4 2014. On a quarter-on-quarter basis, the number of deals decreased and deal values increased in Q4 2015, when compared to 1,053 deals worth USD145.7 billion in Q3 2015. Licensing agreements recorded an increase in upfront payments and milestone payments in Q4 2015. A total of USD867.6m and USD10.4 billion were reported as upfront and milestone payments in Q4 2015, compared to USD729.3m and USD6.5 billion, respectively in Q4 2014. click to purchase - http://www.jsbmarketresearch.com/healthcare-medical/r-partnerships-licensing-investments-and-ma-deals-and-trends- in-pharmaceuticals-q4-2015-180461 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.

More Related